Printed from Voxsanity (voxsanity.com.au) — NCT07598773 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Type 2 Diabetes
Type 2 Diabetes Trial, By Invitation
NCT07598773
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older
- People who have been diagnosed with prediabetes or Type 2 diabetes
- People whose HbA1c (a measure of average blood sugar over time) is below 8%, and whose body mass index (BMI) falls between 18 and 40, calculated from height and weight
- People who are willing to wear a blood sugar monitoring device (Abbott FreeStyle Libre 3/3+) provided by the study, and allow the study team to view the data it collects
- People who are willing to wear other study devices, such as an Oura Ring
- People who are able to read, write, and speak in English
- People who use long-acting insulin must only take it at bedtime — not at any other time of day (short-acting insulin taken as needed at any time is acceptable)
- People whose medications have been stable for at least 30 days before joining, with at least a 30-day supply of each medication
- People whose weight has been stable (within plus or minus 10 pounds) for at least 2 months before joining
- People who personally own an iPhone 6s or newer (running iOS 16.4 or later) or an Android phone running version 12 or newer, and who are willing to use it to download the study app and connect study devices
- People who personally own, or have access to at home, a computer or tablet
- People who live in the North San Francisco Bay area and are willing to travel to Novato, CA for two morning clinic visits at the Buck Institute
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are currently using any Abbott continuous glucose monitor (CGM), whether prescribed by a doctor or bought over the counter
- People whose BMI is below 18 or above 40
- People who have an allergy to dairy or soy
- People who are currently pregnant or breastfeeding
- People who have been diagnosed with Type 1 diabetes or a condition called MODY (Maturity-Onset Diabetes of the Young)
- People who use an insulin pump
- People who are currently taking any of the following types of medication: glucocorticoids (a type of steroid), non-selective beta blockers (such as propranolol), or thiazide diuretics (a type of water pill)
- People who currently use any tobacco products, including cigarettes, vapes, chewing tobacco, or dip
- People who have been hospitalised overnight for any reason in the past 3 months
- People who have a history of pancreatic disease (other than diabetes) or have had a pancreas transplant
- People who have had any active cancer diagnosis within the past 12 months
- People who have had weight-loss (bariatric) surgery or other gut surgery that may affect how the body processes blood sugar or causes delayed stomach emptying
- People who have a long-term illness affecting the liver, heart, or other body systems in a way that is likely to affect blood sugar or interfere with taking part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
By Invitation
Phase
Not Applicable
Sponsor
4YouandMe
Registry
ClinicalTrials.gov
Start date
25 March 2026
Est. completion
1 February 2027
Where this trial is recruiting
🇺🇸 United States
Primary endpoints
Feasibility: Retention; Feasibility: Adherence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.